Hinweis-Modus ist eingeschaltet Ausschalten

DRDR - iShares Healthcare Innovation UCITS ETF USD (Acc) (IE00BYZK4776)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.
 
(%)
IE00BYZK4776
DRDR ISIN
Exchange Traded Funds (ETF)
Fondstyp
BlackRock
Anbieter
8,95 USD
NAV pro Aktie | 12/06/2026
08/09/2016
Startdatum
Nein
Ausschüttung von Dividenden
CEOGES
CFI
DRDR
Ticker
Formed
Status
Equity
Investitionsobjekt
Healthcare
Sektor
Global
Geographie
iSTOXX® FactSet Breakthrough Healthcare Index
Benchmark
0.4 %
Gesamtkostenquote
1.002,13 Mio. USD
Gesamtes Fondsvermögen | 12/06/2026
1.002,13 Mio. USD
Aktien-Anlageklasse Volumen | 12/06/2026
Ja
UCITS

Rendite auf 12/06/2026, London S.E.

  • YTD
    -5,27 %
  • 1M
    -5,59 %
  • 3M
    -6,19 %
  • 6M
    -3,8 %
  • 1J
    15,51 %
  • 3J
    3,77 %
  • 5J
    -
  • 10J
    -
Zum Börsenpreis einschliesslich Einkommenszahlungen

Letzte Daten zum
Zum Vergleichen hinzufügen

Kurse (DRDR)

Entdecken Sie die umfangreichste Datenbank

1 000 000

Anleihen weltweit

80 234

Aktien

167 970

ETF & Funds

80 000

Indizes

Verwalten Sie Ihr Portfolio auf effizienteste Weise

  • Bond-Screener
  • Watchlist
  • Excel-Add-In

Kurs-Dynamik

Fund profile

The iShares Healthcare Innovation UCITS ETF seeks to replicate as close as possible the price and yield performance of the STOXX Global Breakthrough Healthcare Index by investing in a portfolio comprised primarily of global companies in the healthcare sector

DRDR profile

The iShares Healthcare Innovation UCITS ETF USD (Acc) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Healthcare sector located in Global. The BlackRock fund’s base currency is USD and the share class was registered 08.09.2016 with unique ISIN - IE00BYZK4776. Main exchange is London S.E. and ticker symbol is DRDR. The total expense ratio is 0.4%. The iShares Healthcare Innovation UCITS ETF USD (Acc) pays dividends 0 time(s) per year.

Struktur DRDR auf 11/06/2026

Wertpapier Wertpapier
ILLUMINA INC 2,89%
UCB SA 2,54%
MODERNA INC 2,39%
JOHNSON & JOHNSON 2,33%
MERCK & CO INC 2,27%
BIOGEN INC 2,26%
NATERA INC 2,03%
GUARDANT HEALTH INC 2,02%
NEUROCRINE BIOSCIENCES INC 2%
GLAXOSMITHKLINE 1,96%
NOVARTIS AG 1,96%
AMGEN INC 1,85%
EXELIXIS INC 1,82%
ABBVIE INC 1,82%
ROCHE PS PAR AG 1,81%
THERMO FISHER SCIENTIFIC INC 1,76%
GILEAD SCIENCES INC 1,75%
BRISTOL MYERS SQUIBB 1,74%
IQVIA HOLDINGS INC 1,73%
EDWARDS LIFESCIENCES CORP 1,73%
GENMAB 1,66%
PFIZER INC 1,65%
AGILENT TECHNOLOGIES INC 1,64%
REVVITY INC 1,49%
BEONE MEDICINES AG 1,49%
CELLTRION INC 1,47%
MEDPACE HOLDINGS INC 1,42%
MEDTRONIC PLC 1,4%
DANAHER CORP 1,37%
DEXCOM INC 1,36%
LONZA GROUP AG 1,34%
AXSOME THERAPEUTICS INC 1,21%
INTUITIVE SURGICAL INC 1,19%
CHARLES RIVER LABORATORIES INTERNA 1,15%
SAMSUNG BIOLOGICS LTD 1,1%
HALOZYME THERAPEUTICS INC 1,08%
BIO TECHNE CORP 1,05%
ABBOTT LABORATORIES 1,02%
QIAGEN NV 0,94%
ALKERMES 0,92%
LANTHEUS HOLDINGS INC 0,9%
REPLIGEN CORP 0,87%
SHIMADZU CORP 0,86%
TG THERAPEUTICS INC 0,86%
EISAI LTD 0,84%
SARTORIUS PREF AG 0,82%
IPSEN SA 0,81%
PRO MEDICUS LTD 0,8%
BIO RAD LABORATORIES INC CLASS A 0,77%
INSULET CORP 0,76%
PTC THERAPEUTICS INC 0,74%
ASAHI INTECC LTD 0,74%
BOSTON SCIENTIFIC CORP 0,73%
TEMPUS AI INC CLASS A 0,64%
RHYTHM PHARMACEUTICALS INC 0,63%
PRAXIS PRECISION MEDICINES INC 0,63%
LIGAND PHARMACEUTICALS INC 0,61%
SYSMEX CORP 0,58%
SECTRA CLASS B 0,57%
LIVANOVA PLC 0,55%
TWIST BIOSCIENCE CORP 0,51%
BIOMERIEUX SA 0,48%
CATALYST PHARMACEUTICALS INC 0,47%
SIEGFRIED HOLDING AG 0,47%
CG ONCOLOGY INC 0,44%
VERACYTE INC 0,44%
MAXIMUS INC 0,44%
10X GENOMICS INC CLASS A 0,41%
BEAM THERAPEUTICS INC 0,37%
ADAPTIVE BIOTECHNOLOGIES CORP 0,35%
BACHEM HOLDING AG 0,33%
ACADIA PHARMACEUTICALS INC 0,33%
SICHUAN KELUN-BIOTECH BIOPHARM LTD 0,32%
SUPERNUS PHARMACEUTICALS INC 0,32%
IDEAYA BIOSCIENCES INC 0,31%
TECAN GROUP AG 0,31%
BAVARIAN NORDIC 0,28%
KINIKSA PHARMACEUTICALS INTERNATIO 0,28%
ABL BIO INC 0,27%
DIASORIN 0,26%
RELAY THERAPEUTICS INC 0,25%
NEOGEN CORP 0,25%
AURINIA PHARMACEUTICALS INC 0,25%
JEOL LTD 0,25%
ELEKTA B 0,24%
H. LUNDBECK CLASS B 0,23%
NOVOCURE LTD 0,23%
CORVEL CORP 0,23%
AXOGEN INC 0,23%
BIOCRYST PHARMACEUTICALS INC 0,22%
ARCUS BIOSCIENCES INC 0,22%
IMMUNITYBIO INC 0,21%
SK BIOPHARMACEUTICALS LTD 0,2%
ASTRANA HEALTH INC 0,2%
STOKE THERAPEUTICS INC 0,2%
HARMONY BIOSCIENCES HLDG INC 0,2%
FORTREA HOLDINGS INC 0,19%
REMEGEN LTD H 0,19%
SAREPTA THERAPEUTICS INC 0,18%
NOVAVAX INC 0,18%
Andere - %

Andere ETFs und Fonds dieses Anbieters

Ähnliche Etf & Fonds

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} Mio.
    NAV
    {{ item.expense_ratio }}
    Gesamtkostenquote
Sie müssen sich registrieren , um Zugriff zu erhalten.